Chemotherapeutic potential of quercetin on human bladder cancer cells

Journal of Environmental Science and Health - Part A Toxic/Hazardous Substances and Environmental Engineering

Volumn 51, Issue 9, 2016, Pages 776-781

  Oršolić, Nada ^a   Karač, Ivo ^a   Sirovina, Damir ^a   Kukolj, Marina ^a   Kunštić, Martina ^a   Gajski, Goran ^b   Garaj Vrhovac, Vera ^b   Štajcar, Damir ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^c Varazdin General Hospital   (Croatia)

Author keywords

Antiproliferative action; bladder cancer cells; cytotoxicity; DNA damage; quercetin

Indexed keywords

CELL PROLIFERATION; CYTOLOGY; CYTOTOXICITY; DISEASES; DNA; FLAVONOIDS; PHENOLS;

ANTI-PROLIFERATIVE; BLADDER CANCER CELLS; CHEMOTHERAPEUTIC AGENTS; DNA DAMAGES; HUMAN BLADDER CANCER; QUERCETIN; TRANSURETHRAL RESECTIONS; UROTHELIAL CARCINOMA;

CELLS;

DNA; QUERCETIN; ANTINEOPLASTIC AGENT;

AGED; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER STAGING; CELL VIABILITY; CLINICAL ARTICLE; CLONOGENIC ASSAY; COLONY FORMATION; COMET ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG EFFICACY; DRUG MECHANISM; GENOTOXICITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIMARY CULTURE; TRANSITIONAL CELL CARCINOMA; CARCINOMA, PAPILLARY; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECTS; TUMOR CELL LINE; URINARY BLADDER NEOPLASMS;

ANTINEOPLASTIC AGENTS; CARCINOMA, PAPILLARY; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COMET ASSAY; DNA DAMAGE; HUMANS; QUERCETIN; URINARY BLADDER NEOPLASMS;

EID: 84965062474     PISSN: 10934529     EISSN: 15324117     Source Type: Journal    
DOI: 10.1080/10934529.2016.1170465     Document Type: Article

References (35)

1. M.Ploeg, ; K.K.Aben, ; L.A.Kiemeney, The present and future burden of urinary bladder cancer in the world. World. J. Urol. 2009, 27(3), 289–293.
2. W.Oosterlinck, ; E.Solsona, ; A.P.van der Meijden, ; R.Sylvester, ; A.Böhle, ; E.Rintala, ; B.Lobel, European Association of Urology. EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur. Urol. 2004, 46(2), 147−154.
3. R.J.Sylvester, ; A.P.van der Meijden, ; W.Oosterlinck, ; J.A.Witjes, ; C.Bouffioux, ; K.Denis L; Newling DW; Kurth, Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials. Eur. Urol. 2006, 49(3), 466−475.
4. L.Rockenbach, ; L.Bavaresco, ; P.Fernandes Farias, ; A.R.Cappellari, ; C.H.Barrios, ; F.Bueno Morrone, ; A.M.Oliveira Battastini, Alterations in the extracellular catabolism of nucleotides are involved in the antiproliferative effect of quercetin in human bladder cancer T24 cells. Urol. Oncol. 2013, 31(7), 1204−1211.
5. A.W.Boots, ; G.R.Haenen, ; A.Bast, Health effects of quercetin: From antioxidant to nutraceutical. Eur. J. Pharmacol. 2008, 585(2−3), 325−337.
6. F.Dajas, Life or death: Neuroprotective and anticancer effects of quercetin. J. Ethnopharmacol. 2012, 143(2), 383−396.
7. M.Russo, ; C.Spagnuolo, ; I.Tedesco, ; S.Bilotto, ; G.L.Russo, The flavonoid quercetin in disease prevention and therapy: Facts and fancies. Biochem. Pharmacol. 2012, 83(1), 6−15.
8. G.Q.D'Andrea, G. Quercetin A flavonol with multifaceted therapeutic applications? Fitoterapia. 2015, 106, 256−271.
9. N.Oršolić, A review of propolis antitumor action in vivo and in vitro. JAAS. 2010, 2, 1−20.
10. M.J.Ruiz, ; M.Fernández, ; P.YPicó; J.Mañes, ; M.Asensi, ; C.Carda, ; G.Asensio, ; J.M.Estrela, Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. J. Agric. Food. Chem. 2009, 57(8), 3180−3186.
11. S.I.Khan, ; J.Zhao, ; I.A.Khan, ; L.A.Walker, ; A.K.Dasmahapatra, Potential utility of natural products as regulators of breast cancer-associated aromatase promoters. Reprod. Biol. Endocrinol. 2011, 9, 91.
12. H.J.Kim, ; S.K.Kim, ; B.S.Kim, ; S.H.Lee, ; Y.S.Park, ; B.K.Park, ; S.J.Kim, ; J.Kim, ; C.Choi, ; J.S.Kim, ; S.D.Cho, ; J.W.Jung, ; K.H.Roh, ; K.S.Kang, ; J.Y.Jung, Apoptotic effect of quercetin on HT-29 colon cancer cells via the AMPK signaling pathway. J. Agric. Food Chem. 2010, 58(15), 8643−8650.
13. K.Wang, ; R.Liu, ; J.Li, ; J.Mao, ; Y.Lei, ; J.Wu, ; J.Zeng, ; T.Zhang, ; H.Wu, ; L.Chen, ; C.Huang, ; Y.Wei, Quercetin induces protective autophagy in gastric cancer cells: Involvement of Akt-mTOR- and hypoxia-induced factor 1α-mediated signaling. Autophagy. 2011, 7(9), 966−978.
14. P.Josipović.; N.Oršolić, Cytotoxicity of polyphenolic/flavonoid compounds in a leukaemia cell culture. Arh. Hig. Rada Toksikol. 2008, 59(4), 299−308.
15. Q.Long, ; Y.Xiel, ; Y.Huang, ; Q.Wu, ; H.Zhang, ; S.Xiong, ; Y.Liu, ; L.Chen, ; Y.Wei, ; X.Zhao, ; C.Gong, Induction of apoptosis and inhibition of angiogenesis by PEGylated liposomal quercetin in both cisplatin-sensitive and cisplatin-resistant ovarian cancers. J. Biomed. Nanotechnol. 2013, 9(6), 965−975.
16. N.Oršolić, ; D.Štajcar, ; I.Bašić, Propolis and its flavonoid compounds cause cytotoxicity on human urinary bladder transitional cell carcinoma in primary culture. Period. Biol. 2009, 111(1), 113−121.
17. R.Vidya Priyadarsini, ; R.Senthil Murugan, ; S.Maitreyi, ; K.Ramalingam, ; D.Karunagaran, ; S.Nagini, The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition. Eur. J. Pharmacol. 2010, 649(1−3), 84−91.
18. R.G.Beniston, ; M.S.Campo, Quercetin elevates p27(Kip1) and arrests both primary and HPV16 E6/E7 transformed human keratinocytes in G1. Oncogene. 2003, 22(35), 5504−5514.
19. N.P.Singh, ; M.T.McCoy, ; R.R.Tice, ; E.L.Schneider, A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175(1), 184−191.
20. V.Garaj-Vrhovac, ; G.Gajski, Evaluation of the cytogenetic status of human lymphocytes after exposure to a high concentration of bee venom in vitro. Arh. Hig. Rada Toksikol. 2009, 60(1), 27−34.
21. A.Reljić, ; D.Tomas, ; T.Gabelić, ; J.Zarubica, ; S.Bulimbašić, ; H.Fazlić, ; H.Čupić, ; B.Krušlin, Stromal reaction in synchrounous in situ and invasive urothelial carcinoma of the bladder. Acta Clin. Croat. 2006, 45, 173−179.
22. R.Yao, ; D.D.Davidson, ; A.Lopez-Beltran, ; G.T.MacLennan, ; R.Montironi, ; L.Cheng, The S100 proteins for screening and prognostic grading of bladder cancer. Histol. Histopathol. 2007, 22(9), 1025−1032.
23. R.H.Liu, Health-promoting components of fruits and vegetables in the diet. Adv. Nutr. 2013, 4(3), 384S−392S.
24. J.Jakubowicz-Gil, ; B.Pawlikowska-Pawlega, ; T.Piersiak, ; J.Pawelec, ; A.Gawron, Quercetin suppresses heat shock-induced nuclear translocation of Hsp72. Folia Histochem. Cytobiol. 2005, 43(3), 123−128.
25. N.Oršolić, ; N.Car, Quercetin and hyperthermia modulate cisplatin-induced DNA damage in tumor and normal tissues in vivo. Tumour Biol 2014, 35(7), 6445−6454.
26. Gasión, J.P.; Cruz, J.F. Improving Efficacy of Intravesical Chemotherapy. Eur. Urol. 2006, 50(2), 225–234.
27. A.Azqueta, ; A.R.Collins, The essential comet assay: A comprehensive guide to measuring DNA damage and repair. Arch. Toxicol. 2013, 87(6), 949−968.
28. G.L.Russo, ; M.Russo, ; C.Spagnuolo, ; I.Tedesco, ; S.Bilotto, ; R.Iannitti, ; R.Palumbo, Quercetin: A pleiotropic kinase inhibitor against cancer. Cancer Treat. Res. 2014, 159, 185−205.
29. R.Yoshimura, ; M.Matsuyama, ; K.Tsuchida, ; Y.Kawahito, ; H.Sano, ; T.Nakatani, Expression of lipoxygenase in human bladder carcinoma and growth inhibition by its inhibitors. J. Urol. 2003, 170(5), 1994−1999.
30. H.Mohseni, ; S.Zaslau, ; D.McFadden, ; D.R.Riggs, ; B.J.Jackson, ; S.Kandzari, COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro. J. Surg. Res. 2004, 119(2), 138−142.
31. A.H.Knežević, ; D.Dikić, ; D.Lisičić, ; N.Kopjar, ; N.Oršolić, ; S.Karabeg, ; V.Benković, Synergistic effects of irinotecan and flavonoids on Ehrlich ascites tumour-bearing mice. Basic Clin. Pharmacol. Toxicol. 2011, 109(5), 343−349.
32. N.Oršolić, ; L.Šver, ; S.Terzić, ; Z.Tadić, ; I.Bašić, Inhibitory effect of water-soluble derivative of propolis and its polyphenolic compounds on tumor growth and metastasizing ability: A possible mode of antitumor action. Nutr. Cancer. 2003, 47(2), 156−163.
33. A.M.Kamat, ; D.L.Lamm, Chemoprevention of bladder cancer. Urol. Clin. North. Am. 2002, 29(1), 157−168.
34. M.P.Koya, ; M.A.Simon, ; M.S.Soloway, Complications of intravesical therapy for urothelial cancer of the bladder. J. Urol. 2006, 175(6), 2004−2010.
35. A.P.Van der Meijden, ; R.J.Sylvester, ; W.Oosterlinck, ; W.Hoeltl, ; A.V.Bono, ; EORTC Genito-Urinary Tract Cancer Group Maintenance Bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: Results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial. Eur. Urol. 2003, 44(4), 429−434.